GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (WBO:MYL) » Definitions » Cyclically Adjusted FCF per Share

Viatris (WBO:MYL) Cyclically Adjusted FCF per Share : €2.24 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Viatris Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Viatris's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.429. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.24 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Viatris's average Cyclically Adjusted FCF Growth Rate was -1.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Viatris was 25.10% per year. The lowest was -1.90% per year. And the median was 10.60% per year.

As of today (2024-05-17), Viatris's current stock price is €10.265. Viatris's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €2.24. Viatris's Cyclically Adjusted Price-to-FCF of today is 4.58.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Viatris was 58.96. The lowest was 3.58. And the median was 17.19.


Viatris Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Viatris's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Cyclically Adjusted FCF per Share Chart

Viatris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.76 1.50 1.90 2.17 2.15

Viatris Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 2.25 2.35 2.15 2.24

Competitive Comparison of Viatris's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Viatris's Cyclically Adjusted Price-to-FCF falls into.



Viatris Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Viatris's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.429/131.7762*131.7762
=0.429

Current CPI (Mar. 2024) = 131.7762.

Viatris Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.171 100.560 0.224
201409 0.107 100.428 0.140
201412 0.113 99.070 0.150
201503 0.432 99.621 0.571
201506 -0.089 100.684 -0.116
201509 0.981 100.392 1.288
201512 0.753 99.792 0.994
201603 -0.136 100.470 -0.178
201606 0.477 101.688 0.618
201609 1.814 101.861 2.347
201612 0.061 101.863 0.079
201703 0.551 102.862 0.706
201706 0.192 103.349 0.245
201709 0.659 104.136 0.834
201712 0.496 104.011 0.628
201803 0.390 105.290 0.488
201806 0.187 106.317 0.232
201809 0.985 106.507 1.219
201812 0.325 105.998 0.404
201903 -0.186 107.251 -0.229
201906 0.877 108.070 1.069
201909 0.754 108.329 0.917
201912 0.982 108.420 1.194
202003 0.316 108.902 0.382
202006 0.559 108.767 0.677
202009 0.764 109.815 0.917
202012 -0.406 109.897 -0.487
202103 0.553 111.754 0.652
202106 0.313 114.631 0.360
202109 0.669 115.734 0.762
202112 0.221 117.630 0.248
202203 0.798 121.301 0.867
202206 0.554 125.017 0.584
202209 0.625 125.227 0.658
202212 -0.018 125.222 -0.019
202303 0.688 127.348 0.712
202306 0.327 128.729 0.335
202309 0.568 129.860 0.576
202312 0.211 129.419 0.215
202403 0.429 131.776 0.429

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Viatris  (WBO:MYL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Viatris's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=10.265/2.24
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Viatris was 58.96. The lowest was 3.58. And the median was 17.19.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Viatris Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Viatris's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Viatris (WBO:MYL) Business Description

Industry
Traded in Other Exchanges
Address
1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris (WBO:MYL) Headlines

No Headlines